Guidelines for Rational Use of Antibiotics in Surgical Prophylaxis

1. The CDC Wound Classification System

2. When to Use Surgical Prophylaxis - Indications

1. All clean-contaminated operations (GI, biliary, gynecologic, urologic)
2. Selected clean procedures where postoperative infection would be catastrophic - open-heart surgery, neurosurgical craniotomy
3. Clean procedures involving prosthetic material - joint replacements, vascular grafts, mesh repairs
4. Any procedure in an immunocompromised host
5. Clean procedures with SENIC risk factors (>1 discharge diagnosis, abdominal surgery, operation >2 hours, contaminated/dirty wound class)

• Fischer's Mastery of Surgery, 8th ed.
• Katzung's Basic and Clinical Pharmacology, 16th ed.

3. Six Core Principles of Rational Antibiotic Selection

1. Target the likely pathogens - the antibiotic must cover common wound pathogens for that procedure; unnecessarily broad coverage must be avoided
2. Proven clinical efficacy - use agents with established evidence in clinical trials
3. Adequate tissue concentrations - concentrations must exceed the MIC of suspected pathogens and must be present at the time of incision throughout the procedure
4. Shortest effective course - ideally a single dose; avoid postoperative continuation beyond 24 hours
5. Preserve newer agents - broad-spectrum antibiotics should be reserved for treating resistant infections, not prophylaxis
6. Cost-effectiveness - when other factors are equal, use the least expensive effective agent

• Katzung's Basic and Clinical Pharmacology, 16th ed., p. 1424

4. Timing of Administration

• Give within 60 min before incision for most agents
• Give within 120 min before incision for vancomycin and fluoroquinolones
• For cesarean section: administer after umbilical cord clamping (traditional) - though current evidence supports pre-incision dosing
• When a tourniquet is used: complete the infusion at least 5 minutes before tourniquet inflation
• Do not give too early - if incision is more than 60 minutes after the dose, tissue levels may be subtherapeutic

5. Agent of Choice by Procedure

6. Dosing and Redosing

Standard Adult Doses

Intraoperative Redosing Rules

• Redose when procedure duration exceeds 2x the half-life of the drug (e.g., redose cefazolin every 4 hours intraoperatively)
• Redose with significant blood loss (~0.5 to 1 blood volume)
• Redosing intervals may be extended in renal insufficiency
• Fischer's Mastery of Surgery, 8th ed., Table 9.10

7. Duration of Prophylaxis

• Single-dose prophylaxis is effective for most procedures and is the ideal
• If postoperative dosing is chosen, discontinue within 24 hours of the operative end time (48 hours for cardiac surgery in some guidelines)
• Prolonging antibiotics beyond 24 hours does NOT reduce SSI risk but significantly increases:
  • Antibiotic resistance
  • Clostridioides difficile infection
  • Drug toxicity and adverse effects
  • Cost
• Antibiotics should not be continued solely because a wound drain is in place (WHO strong recommendation)
• Barash Clinical Anesthesia, 9th ed., p. 570
• Jawetz Medical Microbiology, 28th ed.

8. Special Situations

Penicillin/Beta-Lactam Allergy

• A reported penicillin allergy is almost never a true contraindication to cefazolin - cross-reactivity between penicillin and cephalosporins is much lower (~1%) than previously believed
• A documented history of anaphylaxis, angioedema, urticaria, bronchospasm, SJS, or TEN is the exception where cefazolin should be avoided
• Always assess the severity and nature of the allergic reaction before choosing an alternative - choosing an inferior alternative when none is needed increases risk and cost
• Barash Clinical Anesthesia, 9th ed.

MRSA Colonization

• Pre-surgical nares surveillance screening for MRSA using culture or NAAT (nucleic acid amplification) is recommended
• MRSA-positive patients: treat with mupirocin nasal ointment (3-5 days) + chlorhexidine bathing before surgery
• Consider adding vancomycin to cefazolin for intraoperative prophylaxis in known MRSA carriers
• Vancomycin alone is not recommended for routine surgical prophylaxis even in hospitals with high MRSA rates, but may substitute cefazolin when MRSA rates are very high
• Jawetz Medical Microbiology, 28th ed.

Obesity

• Standard doses may be inadequate - weight-based dosing is preferred
• Cefazolin: 3 g for patients ≥120 kg
• Cefotaxime: 2 g for obese patients

Immunocompromised Patients

• Any procedure in an immunocompromised host warrants prophylaxis regardless of wound class
• Patients with neutropenia (<1000/μL) undergoing surgery may need extended empiric coverage targeting gram-negative organisms

When Therapeutic Antibiotics Are Already Given

• If therapeutic antibiotics are being administered preoperatively for an active infection (e.g., acute appendicitis), separate prophylactic antibiotics are not required
• Coverage of skin flora at incision may still be added in some cases

9. Additional Measures to Prevent SSI (Non-Antibiotic)

• WHO Global Guidelines for SSI Prevention

10. Antimicrobial Stewardship Principles in Surgical Prophylaxis

• Right drug - narrowest spectrum active against likely pathogens
• Right dose - weight-adjusted, pharmacokinetically appropriate
• Right time - within 60 min before incision
• Right duration - single dose or maximum 24 hours
• Use of a pharmacist-led or multidisciplinary perioperative stewardship program significantly improves adherence to guidelines and reduces SSI rates (systematic review evidence: Naseralallah et al., 2024, PMID 39153871)
• Local antibiogram data should guide agent selection - if institutional MRSA rates are high, adjust prophylaxis accordingly
• Hospital committees should determine protocols based on national guidelines + local resistance patterns

Key Takeaway Summary